Portland Communications
Vertex continues upward trajectory with French Orkambi deal
Comes on the heels of similar reimbursement deal in England
Vertex, NHS England and NICE finally reach agreement for Orkambi
Deal also includes Vertex’s other licensed cystic fibrosis medicines
Labour Party takes aim at pharma, calls attention to Orkambi row
Proposal to introduce compulsory licensing faces industry criticism
Orkambi row: government now considering Crown Use licensing
MPs call for radical solutions as deadlock remains
Buyers’ Club wants government support on Orkambi imports
Proposes three point plan to work round impasse
Still no breakthrough on Orkambi talks, MPs want answers
As other price deals go through, Orkambi stalled again
Vertex: a vision of treating all CF patients worldwide draws closer
Its high prices are controversial, but Vertex also embodies the best of biopharma drug development
The Orkambi row explained
Q&A and timeline